Kush Parmar is Director & 10% Owner at Homology Medicines, Inc. (FIXX). They have made 24 open-market trades across 8 companies since 2018, most recently 2026-08-10.
CIK 0001664281
7 open-market purchases totalling $48.6M since 2020, against 17 sales. Across 7 scored buys the stock is down 16.9% at ninety days, and 19.6 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 14% | 29% |
| Avg Move | +6.4% | -5.6% | -16.9% |
| Alpha | +7.6% | -5.4% | -19.6% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 69% | 62% | 50% |
| Avg Move | -4.1% | -7.4% | +0.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRDA | SELL | 2026-08-06 | 2026-08-10 | $6.95 | $1.1M | +8.1% | +1.3% | — |
| TRDA | SELL | 2026-07-30 | 2026-08-03 | $6.93 | $807K | +0.8% | -1.1% | — |
| TRDA | SELL | 2025-11-14 | 2025-11-18 | $8.80 | $3.5M | +13.6% | +25.7% | +26.4% |
| TRDA | SELL | 2025-07-09 | 2025-07-11 | $7.50 | $405K | -1.7% | -22.8% | +4.5% |
| TRDA | SELL | 2025-06-27 | 2025-07-01 | $6.93 | $1.6M | -4.4% | -17.3% | -17.9% |
| SKYE | BUY | 2024-03-13 | 2024-03-15 | $10.00 | $4.5M | +9.7% | -3.7% | -20.1% |
| RLYB | SELL | 2023-03-07 | 2023-03-09 | $8.20 | $1.6M | -10.2% | -8.6% | +54.6% |
| RLYB | SELL | 2022-06-03 | 2022-06-07 | $12.50 | $3.8M | -3.7% | +13.1% | +51.3% |
| RLYB | SELL | 2022-05-23 | 2022-05-25 | $13.00 | $1.3M | -41.4% | -38.5% | -17.6% |
| RLYB | SELL | 2022-02-08 | 2022-02-10 | $13.05 | $5.5M | -17.7% | -29.3% | -30.5% |
| CINC | BUY | 2022-01-11 | 2022-01-13 | $16.00 | $7.5M | +6.3% | +41.7% | +28.2% |
| VOR | SELL | 2021-11-16 | 2021-11-18 | $15.30 | $6.5M | -18.6% | -12.1% | -32.7% |
| TRDA | BUY | 2021-11-02 | 2021-11-05 | $20.00 | $5.0M | +50.1% | -4.5% | -61.1% |
| RLYB | BUY | 2021-08-02 | 2021-08-04 | $13.00 | $8.0M | -22.6% | -29.8% | -5.4% |
| IMPL | BUY | 2021-04-27 | 2021-04-29 | $15.00 | $8.6M | -3.6% | -34.4% | -16.5% |
| VOR | BUY | 2021-02-09 | 2021-02-09 | $18.00 | $10.0M | +3.6% | -3.4% | -50.1% |
| AKUS | SELL | 2020-12-29 | 2020-12-31 | $18.00 | $8.5M | -11.9% | -20.1% | -29.9% |
| FIXX | SELL | 2020-12-22 | 2020-12-28 | $12.82 | $6.4M | +4.0% | +1.5% | -25.3% |
| FIXX | SELL | 2020-12-14 | 2020-12-16 | $12.25 | $12.3M | +1.0% | +13.1% | -12.2% |
| AKUS | BUY | 2020-06-30 | 2020-07-02 | $17.00 | $5.0M | +1.6% | -4.8% | +7.1% |
| FIXX | SELL | 2019-05-16 | 2019-05-20 | $21.47 | $13.2M | -8.3% | -13.3% | -20.3% |
| FIXX | SELL | 2018-12-10 | 2018-12-12 | $26.01 | $794K | -18.1% | +1.6% | +6.1% |
| FIXX | SELL | 2018-11-23 | 2018-11-27 | $20.04 | $1.2M | +30.1% | +5.2% | +33.6% |
| FIXX | SELL | 2018-11-16 | 2018-11-20 | $20.20 | $21.2M | +27.8% | +12.5% | +30.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| IMPL | 2,309,791 | $557K |
| ARVN | 1,775 | $12K |
| FVAM | 365,126 | — |
| Total | $318.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 13 | 13 | 12 |